AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16374480 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 40
Study 16374480 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated arms)
Number of subjects: 40
Study 10918923 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir liquid (80 mL, 10 mg/mL)
Number of subjects: 12
Study 10918923 — intervention group
Group type: COMPARATOR
Intervention: Indinavir capsules (800 mg as two 400-mg capsules)
Number of subjects: 12
Study 10918923 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir liquid and capsules
Number of subjects: 12
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative flexion less than 90 degrees
Number of subjects: 621
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative flexion 91 to 105 degrees
Number of subjects: 621
Study 8895623 — intervention group
Group type: COMPARATOR
Intervention: Preoperative flexion greater than 105 degrees
Number of subjects: 621
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative knee score less than 27
Number of subjects: 621
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative knee score 28 to 40
Number of subjects: 621
Study 8895623 — intervention group
Group type: COMPARATOR
Intervention: Preoperative knee score greater than 40
Number of subjects: 621
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative functional score less than 40
Number of subjects: 621
Study 8895623 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative functional score 41 to 50
Number of subjects: 621
Study 8895623 — intervention group
Group type: COMPARATOR
Intervention: Preoperative functional score greater than 50
Number of subjects: 621
Study 2049240 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg
Number of subjects: 18
Study 2049240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole 1.200 mg/m2 orally on each treatment day
Number of subjects: 67
Study 6303553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 6303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 67
Study 30575426 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin (from CANVAS trial)
Number of subjects: 0
Study 30575426 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (from EMPA-REG trial)
Number of subjects: 0
Study 30656169 — intervention group
Group type: EXPERIMENTAL
Intervention: Stability exercise (SE)
Number of subjects: 30
Study 30656169 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercise (BE)
Number of subjects: 30
Study 27866658 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) with modulated electrohyperthermia (mEHT)
Number of subjects: 12
Study 27866658 — intervention group
Group type: COMPARATOR
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 12
Study 27866658 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulated electrohyperthermia (mEHT)
Number of subjects: 12
Study 24580023 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 267
Study 22650145 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection using cervical Jiaji (EX‐B 2), Fengchi (GB 20), Ashi points, etc. with medications including simple Chinese herbs (Danggui injection, etc.), compound Chinese herbs (compound Danggui injection, etc.), simple western medicine (vitamin B family, etc.), and Chinese herbs combined with western medicine (compound Danggui injection combined with vitamin B12, etc.)
Number of subjects: 0
Study 20606481 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg orally thrice a day for 3 months
Number of subjects: 325
Study 20606481 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 325
Study 20606481 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving NAC)
Number of subjects: 325
Study 18001211 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg purified isoflavones administered in 2 divided doses of 40 mg for 12 weeks
Number of subjects: 53
Study 18001211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 15683483 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered biatrial pacing (BIP-AAT; n = 50)
Number of subjects: 72
Study 15683483 — intervention group
Group type: COMPARATOR
Intervention: Single right atrial pacing (RAP-AAI; n = 22)
Number of subjects: 72
Study 15683483 — intervention group
Group type: EXPERIMENTAL
Intervention: Triggered biatrial pacing (BIP-AAT)
Number of subjects: 72
Study 15683483 — intervention group
Group type: COMPARATOR
Intervention: Single right atrial pacing (RAP-AAI)
Number of subjects: 72
Study 11858482 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. melagatran (1, 2 or 4 mg bid) for 2 days followed by oral ximelagatran (6, 12 or 24 mg bid) for 6-9 days
Number of subjects: 136
Study 11858482 — intervention group
Group type: COMPARATOR
Intervention: dalteparin 5000 IU s.c. once daily for 8-11 days
Number of subjects: 136
Study 11858482 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. melagatran plus oral ximelagatran
Number of subjects: 136
Study 11858482 — intervention group
Group type: EXPERIMENTAL
Intervention: ximelagatran and melagatran
Number of subjects: 136
Study 10421921 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 30
Study 10421921 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 30
Study 7559370 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (average dosage of approximately 350 mg/day during Weeks 2 to 4)
Number of subjects: 93
Study 7559370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 31412937 — intervention group
Group type: EXPERIMENTAL
Intervention: Peek Community Eye Health system (Peek CEH)
Number of subjects: 0
Study 31412937 — intervention group
Group type: COMPARATOR
Intervention: Current care (periodic health centre‐based outreach clinics)
Number of subjects: 0
Study 28786523 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer 3200 mg
Number of subjects: 15
Study 28786523 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK (0.4 pmol sulfated CCK-8/kg/min)
Number of subjects: 15
Study 28786523 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15
Study 26452769 — intervention group
Group type: EXPERIMENTAL
Intervention: Processes of Change (Self-Liberation)
Number of subjects: 2718
Study 26452769 — intervention group
Group type: EXPERIMENTAL
Intervention: Processes of Change (Reinforcement Management)
Number of subjects: 2718
Study 26452769 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall use of Processes of Change
Number of subjects: 2718
Study 25268516 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg once daily for a maximum of 28 days
Number of subjects: 540
Study 25268516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 21959675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tango dancing program (twice weekly for 12 months)
Number of subjects: 62
Study 21959675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tango dancing program
Number of subjects: 62
Study 21959675 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 19733053 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine/epinephrine/fentanyl mixture
Number of subjects: 100
Study 19733053 — intervention group
Group type: COMPARATOR
Intervention: 0.5% levobupivacaine
Number of subjects: 100
Study 17324398 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg at weeks 0, 2, and 6, followed by maintenance therapy every 8 weeks
Number of subjects: 112
Study 17324398 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg every 8 weeks
Number of subjects: 112
Study 17324398 — intervention group
Group type: COMPARATOR
Intervention: Infliximab 5 mg/kg every 12 weeks
Number of subjects: 112
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU)
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Cognitive Behavioral Therapy (CCBT)
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT/Fluoxetine (CCBT/FLU)
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT/Placebo (CCBT/PBO)
Number of subjects: 295
Study 15466674 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: CCBT
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU) and CCBT/FLU
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: All active treatments
Number of subjects: 295
Study 15466674 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (CCBT/FLU)
Number of subjects: 295
Study 11799259 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-a) administered at a dosage of 3 million units three times weekly for 1 year
Number of subjects: 30
Study 11799259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IFN-a treatment)
Number of subjects: 30
Study 9723642 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 0
Study 9723642 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 7989854 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework practices and adaptations used by general education teachers
Number of subjects: 441
Study 7989854 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences in homework practices and adaptations across educational levels (elementary, middle, high school)
Number of subjects: 441
Study 7989854 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional implications of identified homework practices
Number of subjects: 441
Study 2972597 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (0.5 mg/kg as a bolus)
Number of subjects: 20
Study 2972597 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (5 micrograms/kg.min)
Number of subjects: 20
Study 4461977 — intervention group
Group type: EXPERIMENTAL
Intervention: Massed Practice (MP)
Number of subjects: 60
Study 4461977 — intervention group
Group type: COMPARATOR
Intervention: Distributed Practice (DP)
Number of subjects: 60
Study 31444535 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient pelvic floor muscle training (PFMT)
Number of subjects: 69
Study 31444535 — intervention group
Group type: COMPARATOR
Intervention: Home pelvic floor muscle training (PFMT)
Number of subjects: 69
Study 31444535 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient PFMT
Number of subjects: 69
Study 31444535 — intervention group
Group type: COMPARATOR
Intervention: Home PFMT
Number of subjects: 69
Study 30866669 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient Powder (MNP)
Number of subjects: 130
Study 30866669 — intervention group
Group type: EXPERIMENTAL
Intervention: Bigas-Mongo (BigMo) complementary food blend
Number of subjects: 130
Study 30866669 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) promotion of MNP and BigMo
Number of subjects: 130
Study 28628969 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at DU20 acupoint with a frequency of 2‐10 Hz and intensity of 1‐5 mA
Number of subjects: 54
Study 28628969 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 100 μg/kg/min
Number of subjects: 54
Study 25133519 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video game (AVG) for 60 minutes
Number of subjects: 24
Study 25133519 — intervention group
Group type: COMPARATOR
Intervention: Seated rest (SR)
Number of subjects: 24
Study 22712560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound pre-treatment (1 MHz, 1 W/cm²)
Number of subjects: 0
Study 22712560 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound simultaneous treatment (1 MHz, 1 W/cm²)
Number of subjects: 0
Study 21942857 — intervention group
Group type: EXPERIMENTAL
Intervention: Google Calendar
Number of subjects: 12
Study 21942857 — intervention group
Group type: COMPARATOR
Intervention: Standard diary
Number of subjects: 12
Study 18652325 — intervention group
Group type: EXPERIMENTAL
Intervention: Deeply needling Qiangji 4 points
Number of subjects: 279
Study 18652325 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture therapy
Number of subjects: 279
Study 16998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary repair buttressed with small intestinal submucosa (SIS), n = 51
Number of subjects: 108
Study 16998356 — intervention group
Group type: COMPARATOR
Intervention: Primary repair (1 degrees), n = 57
Number of subjects: 108
Study 16998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SIS and 1 degrees)
Number of subjects: 108
Study 16998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with recurrent hernia
Number of subjects: 108
Study 14580630 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice‐individualized facilitation of implementation of tools and approaches
Number of subjects: 77
Study 10945015 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary guidance plus ingestion of wheat bran biscuits (Regimen II)
Number of subjects: 200
Study 10945015 — intervention group
Group type: COMPARATOR
Intervention: Dietary guidance alone (Regimen I)
Number of subjects: 200
Study 8980974 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (n = 32)
Number of subjects: 48
Study 8980974 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 48
Study 1727835 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 166): Low-to-moderate-intensity endurance training, 40 minutes thrice weekly on a cycle ergometer, with training heart rate set at 70% of peak heart rate.
Number of subjects: 247
Study 1727835 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (n = 81): Attended weekly group talks.
Number of subjects: 247
Study 1727835 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 166): Low-to-moderate-intensity endurance training.
Number of subjects: 247
Study 6747548 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory condition (children instructed to memorize a subset of toys)
Number of subjects: 180
Study 6747548 — intervention group
Group type: COMPARATOR
Intervention: Play groups (control groups)
Number of subjects: 180
Study 6747548 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory condition
Number of subjects: 180
Study 6747548 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory condition (oldest subjects)
Number of subjects: 180
Study 30210024 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with volume guarantee (PSV+VG)
Number of subjects: 40
Study 30210024 — intervention group
Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 40
Study 27289276 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 157
Study 27289276 — intervention group
Group type: COMPARATOR
Intervention: Fresh-frozen allograft
Number of subjects: 157
Study 24824900 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitative exercise training (RET)
Number of subjects: 47
Study 24824900 — intervention group
Group type: COMPARATOR
Intervention: Standard of care rehabilitation (SOC)
Number of subjects: 47
Study 22918828 — intervention group
Group type: EXPERIMENTAL
Intervention: FDM-guided treatment
Number of subjects: 60
Study 22918828 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual therapy (MT)
Number of subjects: 60
Study 20224951 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 139
Study 20224951 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 139
Study 20224951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 18578221 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence interventions
Number of subjects: 63
Study 18578221 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 63
Study 15277626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia (endovascular cooling device targeting 33 degrees C for 24 hours)
Number of subjects: 40
Study 15277626 — intervention group
Group type: COMPARATOR
Intervention: Standard medical management (control group)
Number of subjects: 40
Study 15277626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia (in patients who cooled well)
Number of subjects: 40
Study 11865386 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg/kg clonidine
Number of subjects: 50
Study 11865386 — intervention group
Group type: COMPARATOR
Intervention: 100 microg/kg midazolam
Number of subjects: 50
Study 9822003 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 88
Study 9822003 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental presence during induction of anesthesia
Number of subjects: 88
Study 9822003 — intervention group
Group type: COMPARATOR
Intervention: Control (no parental presence or premedication)
Number of subjects: 88
Study 8121459 — intervention group
Group type: EXPERIMENTAL
Intervention: c7E3 Fab bolus and infusion
Number of subjects: 2099
Study 8121459 — intervention group
Group type: EXPERIMENTAL
Intervention: c7E3 Fab bolus alone
Number of subjects: 2099
Study 8121459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2099
Study 2763031 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotamine and heparin (DHE/Hep)
Number of subjects: 21
Study 2763031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 663049 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ear feedback
Number of subjects: 20
Study 663049 — intervention group
Group type: COMPARATOR
Intervention: Left ear feedback
Number of subjects: 20
Study 31136546 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE (80% V˙o2peak)
Number of subjects: 22
Study 31136546 — intervention group
Group type: EXPERIMENTAL
Intervention: AE-BFR (40% V˙o2peak)
Number of subjects: 22
Study 31136546 — intervention group
Group type: EXPERIMENTAL
Intervention: AE (40% V˙o2peak)
Number of subjects: 22
Study 31136546 — intervention group
Group type: COMPARATOR
Intervention: CON (50% of BFR)
Number of subjects: 22
Study 29437501 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique for uvuloplasty (sacrificing one hemi-uvula and centralizing the remaining one)
Number of subjects: 40
Study 29437501 — intervention group
Group type: COMPARATOR
Intervention: Conventional uvula repair (combining the 2 hemi-uvulae)
Number of subjects: 40
Study 27434512 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted group activity with Paro, 30 minutes twice a week for 12 weeks
Number of subjects: 53
Study 27434512 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 53
Study 27434512 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted group activity with Paro
Number of subjects: 53
Study 24633297 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 44
Study 24633297 — intervention group
Group type: COMPARATOR
Intervention: Control (no umbilical cord milking)
Number of subjects: 44
Study 23500269 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 23500269 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 0
Study 23500269 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol (CRT-D subgroup)
Number of subjects: 0
Study 23500269 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol (CRT-D with LBBB subgroup)
Number of subjects: 0
Study 20075055 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level PS of 20 cmH(2)O (PS 20)
Number of subjects: 13
Study 20075055 — intervention group
Group type: COMPARATOR
Intervention: Unassisted exercise
Number of subjects: 13
Study 20075055 — intervention group
Group type: COMPARATOR
Intervention: Sham PS
Number of subjects: 13
Study 20075055 — intervention group
Group type: COMPARATOR
Intervention: Low-level PS of 10 cmH(2)O (PS 10)
Number of subjects: 13
Study 18252756 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (16 lessons on healthy eating, physical activity, and reducing TV viewing over 5 months)
Number of subjects: 679
Study 18252756 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 679
Study 15876467 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon alpha‐2b (1.5 microg/kg) and ribavirin (400‐800 mg)
Number of subjects: 24
Study 15876467 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antiviral therapy)
Number of subjects: 24
Study 12828103 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (1g by continuous i.v. infusion starting 30 minutes before ERCP and continuing for 12 hours afterward)
Number of subjects: 30
Study 12828103 — intervention group
Group type: COMPARATOR
Intervention: Placebo (17 patients)
Number of subjects: 30
Study 11063441 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (250 IU RRR‐alpha‐tocopherol 3 times/d for 1 year)
Number of subjects: 44
Study 11063441 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months followed by Vitamin E supplementation (250 IU RRR‐alpha‐tocopherol 3 times/d for an additional 6 months)
Number of subjects: 44
Study 9206238 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening body resistance method
Number of subjects: 2
Study 9206238 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment (Control)
Number of subjects: 2
Study 1579221 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame (40 mg/kg)
Number of subjects: 10
Study 1579221 — intervention group
Group type: COMPARATOR
Intervention: Sucrose-sweetened drink
Number of subjects: 10
Study 6376482 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 0
Study 6376482 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 6376482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0